Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-098365
Filing Date
2025-07-24
Accepted
2025-07-24 16:30:04
Documents
1
Period of Report
2025-07-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11406
  Complete submission text file 0000950170-25-098365.txt   12945
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address
Moin Andrew (Reporting) CIK: 0001996040 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 251147356